article thumbnail

BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies

Frost & Sullivan

BiBo Pharma is breaking capacity barriers and reducing antibody drug production costs from the international average of hundreds of dollars to just $10 per gram, offering disruptive solutions to global biopharmaceutical companies. times compared to the current 15,000L (total volume) standard in large-scale biopharmaceutical production.

article thumbnail

Leadership in Biopharma: Key thought leaders in the Biopharma industry

Jake Jorgovan

Top 12 Biopharma Thought Leaders in 2024 1. With a rich background in biopharmaceuticals and a clear vision for integrating technology into marketing strategies, Figueiredo White is reshaping how biopharma companies interact with their audiences. Brian Schneider Business website: Rosa & Co.

Biopharma 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aragen Life Sciences Ltd. receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery and Development Services

Frost & Sullivan

San Antonio, TX — 24th July, 2024 — Frost & Sullivan has recognized Aragen Life Sciences, a world-class contract research, development, and manufacturing organization (CRDMO), with the 2024 Global Customer Value Leadership Award. Visit www.aragen.com for more details. The post Aragen Life Sciences Ltd.

article thumbnail

ASCO 2024 Round Up: Advancements in Biomarker-Driven Medicines, Cancer Vaccines, and AI Applications Paving the Way for Expansion of Precision Oncology

Frost & Sullivan

The sessions of the American Society of Clinical Oncology ( ASCO ) 2024 conference focused on this year’s theme – The Art and Science of Cancer Care: From comfort to cure. During ASCO 2024, AbbVie unveiled new data from its ADC platform, which is now being used for the development of therapies that specifically target solid tumors.

article thumbnail

Phesi Receives Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform

Frost & Sullivan

Sept 4, 2024 – Frost & Sullivan has recognized Phesi with the 2024 Global Enabling Technology Leadership Award after analyzing the AI-enabled clinical trial design industry. Phesi delivers clinical development analytical products and services to biopharmaceutical companies worldwide. SAN ANTONIO, TX.

article thumbnail

Clinion Applauded by Frost & Sullivan for Enabling Interoperability and Continuity in Clinical Trials Management with its eClinical Solutions

Frost & Sullivan

July 9, 2024 – Frost & Sullivan recently assessed the integrated clinical trial optimization industry and, based on its findings, recognizes Clinion with the 2024 North American Technology Innovation Leadership Award. SAN ANTONIO, TX. The company is an innovator in the clinical trial and data management space.

article thumbnail

J.P Morgan 2024: Insights, Trends, and Tools for Maximizing your Experience

LaVoie Health Science Blog

Looking ahead to 2024, professionals worldwide are eagerly gearing up for one of the most anticipated events in the financial calendar—the J.P. Morgan 2024 experience. As you prepare for 2024, stay informed about the latest advancements in these fields to ensure your conversations and engagements are cutting edge.